1. The effect of dorzolamide 2% on circadian intraocular pressure in cats with primary congenital glaucoma.
- Author
-
Sigle KJ, Camaño-Garcia G, Carriquiry AL, Betts DM, Kuehn MH, and McLellan GJ
- Subjects
- Administration, Ophthalmic veterinary, Animals, Carbonic Anhydrase Inhibitors administration & dosage, Cat Diseases congenital, Cat Diseases physiopathology, Cats, Circadian Rhythm physiology, Female, Glaucoma congenital, Glaucoma drug therapy, Glaucoma physiopathology, Intraocular Pressure physiology, Male, Sulfonamides administration & dosage, Thiophenes administration & dosage, Carbonic Anhydrase Inhibitors therapeutic use, Cat Diseases drug therapy, Glaucoma veterinary, Intraocular Pressure drug effects, Sulfonamides therapeutic use, Thiophenes therapeutic use
- Abstract
Objective: To determine the extent of fluctuation in circadian intraocular pressure (IOP) and the efficacy of topical dorzolamide 2% q 8 h in lowering IOP and blunting circadian fluctuation in IOP in glaucomatous cats., Animals Studied: Seven adult cats with primary congenital glaucoma (PCG)., Procedures: Measurements of IOP and pupil diameter were obtained for both eyes (OU) of each cat q 4 h for 12 days. Cats were housed in a laboratory animal facility with a 12-h light:dark cycle. Baseline values were established for 2 days. For the next 5 days, placebo (1.4% polyvinyl alcohol) was administered OU q 8 h. Dorzolamide 2% was then administered OU q 8 h for a further 5 days. A multivariate mixed linear model was fitted to the data, with parameters estimated from a Bayesian perspective. The 4 am time point was selected as the reference for the purposes of comparisons., Results: Estimated mean IOP for the reference time point pre-treatment was symmetric (about 33 mmHg OU). In all cats, IOP was significantly lower during the diurnal phase, relative to the 4 am measurements, with highest IOP observed 2-6 h after the onset of the dark phase. Circadian fluctuations in IOP were dampened during the treatment period. There was a significant decrease in IOP in all cats during the dorzolamide treatment period (estimated mean for the treatment period reference = 17.9 mmHg OU)., Conclusions: Topical dorzolamide 2% q 8 h is effective in reducing IOP and IOP fluctuation in cats with PCG., (© 2011 American College of Veterinary Ophthalmologists.)
- Published
- 2011
- Full Text
- View/download PDF